Phase Ⅲ clinical trial on immunogenicity and safety of a quadrivalent influenza virus split vaccine in population aged 3 years and above

LIU Shujun; WANG Ping; ZHANG Shangxiao; YUAN Lingfeng; XIA Wei; XIAO Liangliang; FAN Chuanmei; GAN Beifang; HU Shaohua; GONG Lihui; ZHAO Junshi

doi:10.3969/j.issn.1006-3110.2025.09.001

LIU Shujun, WANG Ping, ZHANG Shangxiao, YUAN Lingfeng, XIA Wei, XIAO Liangliang, FAN Chuanmei, GAN Beifang, HU Shaohua, GONG Lihui, ZHAO Junshi

Practical Preventive Medicine ›› 2025, Vol. 32 ›› Issue (9) : 1025-1031.

PDF(755 KB)

Practical Preventive Medicine ›› 2025, Vol. 32 ›› Issue (9) : 1025-1031. DOI: 10.3969/j.issn.1006-3110.2025.09.001

Special Report:Prophylactic Vaccination

Phase Ⅲ clinical trial on immunogenicity and safety of a quadrivalent influenza virus split vaccine in population aged 3 years and above

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 32(9): 1025-1031 https://doi.org/10.3969/j.issn.1006-3110.2025.09.001

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(755 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2025-02-05	2025-09-15
Issue Date
2025-09-02

Please choose a citation manager

Content to export